At the news
? NEUTRALIMPACT 2/10 144 filed Nov 3, 2026 at 16:15 ET
Director Huda Zoghbi filed a Form 144 notice of intent to sell 7,439 shares of Regeneron common stock, with an estimated aggregate market value of approximately $7.22 million based on the filing date. The shares were acquired through a stock option exercise on the same day, and the sale is planned for cash on the open market.
- Filer: Huda Zoghbi, a director of Regeneron Pharmaceuticals
- Shares to be sold: 7,439 shares of common stock
- Estimated aggregate market value: $7,219,262.83
- Shares acquired on 11/03/2026 via stock option exercise from the company
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access